Decreased Nonpolar Amino Acids in Cerebrospinal Fluid of Alzheimer's Disease Patients Revealed by Very High-Field NMR Spectroscopy.

Fiche publication

Date publication

juin 2026

Journal

Journal of proteome research

Auteurs

Membres identifiés du Cancéropôle Est :
Dr OUDART Jean-Baptiste , Pr MAHMOUDI Abd-El-Rachid

Tous les auteurs :
Wuyart A, Martinez A, Oudart JB, Mahmoudi R, Millot JM

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/42339780

Résumé

Alzheimer's disease (AD) is characterized by metabolic dysfunctions, making cerebrospinal fluid (CSF) an ideal biological matrix for characterizing brain metabolism. Very high-field 900 MHz nuclear magnetic resonance (NMR) spectroscopy was used to profile CSF metabolites from 47 patients ( = 27 AD, = 20 non-AD). A total of forty-eight metabolites were identified and quantified. CSF concentrations of four nonpolar amino acids were reduced in AD: l-alanine ( = 0.001), l-valine ( = 0.02), l-leucine ( = 0.04), and l-phenylalanine ( = 0.04) (two-way ANOVA, pathology and sex as factors). No significant differences were observed for the other identified metabolites. A nonpolar amino acid factor (NAAF) was computed as the sum of these four metabolites ( < 0.001). Partial least-squares discriminant analysis (PLS-DA) based on the NAAF yielded moderate group separation (accuracy = 72%, = 0.22, = 0.006). Receiver operating characteristic (ROC) analysis demonstrated that the NAAF achieved the highest discriminatory performance over individual nonpolar amino acids (AUC = 0.83). l-Alanine correlated negatively with CSF tau markers (p-tau: = -0.40, = 0.005; t-tau: = -0.42, = 0.003); the NAAF displayed similar patterns (p-tau: = -0.38, = 0.009; t-tau: = -0.40, = 0.006). Very high-field NMR spectroscopy revealed a depletion of nonpolar amino acids in AD CSF, reflecting metabolic dysregulation in this neurodegenerative disease.